Punjab Samachar

Drug And Gene Delivery Systems Market Worth $786.9 Billion By 2025: Grand View Research, Inc

 Breaking News
  • No posts were found

Drug And Gene Delivery Systems Market Worth $786.9 Billion By 2025: Grand View Research, Inc

September 13
15:19 2019
Drug And Gene Delivery Systems Market Worth $786.9 Billion By 2025: Grand View Research, Inc

Grand View Research, Inc. – Market Research And Consulting
According to report published by Grand View Research, growing efforts towards formulating dosage forms that would help in maximizing the bioavailability of the drug at the target site while increasing the patient convenience are driving the global market growth.

The global Drug And Gene Delivery Systems Market is expected to reach USD 786.9 Billion by 2025, according to a new report by Grand View Research, Inc. Rising investment by the market players to develop innovative drug delivery systems to cater to the demand by the patients as well as to increase the bioavailability at minimum quantity of active pharmaceutical ingredient is driving the market growth. Additionally, increasing focus on R&D of gene delivery systems owing to the high growth potential of gene therapy for the treatment of a wide range of diseases is expected to fuel the market growth in the future.

Drug delivery systems are in a constant evolution along with the changing preference by the patient. For instance, initially, hormone replacement therapy was widely prescribed in the form of pills, whereas, it is now available in the form of prefilled syringes, patches, vaginal rings, gel, and sprays. The principal purpose of development of different forms of delivery systems is to increase the ease of use. Factors such as aesthetics of the delivery systems, price, and amount of API are also considered while designing the drug delivery system.

Japan drug delivery systems market, by route of administration, 2014 – 2025 (USD Billion)

Japan drug delivery systems market, by route of administration, 2014 - 2025 (USD Billion)


Request a Sample Copy of the Global Drug And Gene Delivery Systems Market Research Report @ https://www.grandviewresearch.com/industry-analysis/drug-gene-delivery-devices-market/request/rs1

Further key findings from the study suggest:

  • The market study suggests that oral segment dominated the market in 2015
  • The convenience of use and low manufacturing cost are the prime factors responsible for the dominance of the oral delivery segment
  • Injectable segment is expected to show a lucrative growth rate owing to the introduction of technically advanced injecting devices that enable convenient self-injection
  • North America dominated the market in 2015 and is expected to remain dominant throughout the forecast period owing to highly developed healthcare infrastructure and high healthcare spending
  • Asia pacific is expected to exhibit the fastest growth rate during the forecast period owing to the factors such as rapidly developing economies, growing disposable income, and high adaption of the advanced delivery systems
  • A few of the major market players in drug delivery systems space are F. Hoffmann-La Roche Ltd, Pfizer, Inc., Johnson and Johnson private Ltd, Novartis AG, Becton, Dickinson and Company, and Bayer AG.
  • Major market players in the gene delivery systems space are SiBiono GeneTech Co., Unique N.V., Epeius Biotechnologies Corporation, Human Stem Cells Institute, and Shanghai Sunway Biotech Co., Ltd.

Global gene delivery systems market, by vector, 2015 (%)

Global gene delivery systems market, by vector, 2015 (%)

Have Any Query? Ask Our Experts @ https://www.grandviewresearch.com/inquiry/3463/ibb

Grand View Research has segmented the drug and gene delivery systems market on the basis of route of administration, vectors, methods, and region:

Route of Administration Outlook (Revenue, USD Billion, 2014 – 2025)

  • Oral
  • Inhalation
  • Transdermal
  • Injectable
  • Ocular
  • Nasal
  • Topical

Vector Outlook (Revenue, USD Million, 2014 – 2025)

  • Viral
  • Non-viral

Method Outlook (Revenue, USD Million, 2014 – 2025)

  • In situ
  • Ex vivo

Regional Outlook (Revenue, USD Billion, 2014 – 2025)

  • North America
    • U.S. Drug Delivery Systems Market, by Route of Administration
    • U.S. Gene Delivery Systems Market, by Vectors
    • U.S. Gene Delivery Systems Market, by Method
    • Canada Drug Delivery Systems Market, by Route of Administration
    • Canada Gene Delivery Systems Market, by Vectors
    • Canada Gene Delivery Systems Market, by Method
  •  Europe
    • UK Drug Delivery Systems Market, by Route of Administration
    • UK Gene Delivery Systems Market, by Vectors
    • UK Gene Delivery Systems Market, by Method
    • Germany Drug Delivery Systems Market, by Route of Administration
    • Germany Gene Delivery Systems Market, by Vectors
    • Germany Gene Delivery Systems Market, by Method
  • Asia Pacific
    • Japan Drug Delivery Systems Market, by Route of Administration
    • Japan Gene Delivery Systems Market, by Vectors
    • Japan Gene Delivery Systems Market, by Method
    • China Drug Delivery Systems Market, by Route of Administration
    • China Gene Delivery Systems Market, by Vectors
    • China Gene Delivery Systems Market, by Method
  • Latin America
    • Brazil Drug Delivery Systems Market, by Route of Administration
    • Brazil Gene Delivery Systems Market, by Vectors
    • Brazil Gene Delivery Systems Market, by Method
    • Mexico Drug Delivery Systems Market, by Route of Administration
    • Mexico Gene Delivery Systems Market, by Vectors
    • Mexico Gene Delivery Systems Market, by Method
  •  MEA
    • South Africa Drug Delivery Systems Market, by Route of Administration
    • South Africa Gene Delivery Systems Market, by Vectors
    • South Africa Gene Delivery Systems Market, by Method

Browse Related Category @

Antidiabetics Market: Growing worldwide prevalence of diabetes (both type I and type II) is expected to be a key driver for insulin and oral hypoglycemic drugs demand.

Contraceptives Market: The global contraceptives market is estimated to grow at a lucrative rate over the forecast period owing to, increasing the prevalence of sexually transmitted diseases and growing need for population control

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: www.grandviewresearch.com/industry-analysis/drug-gene-delivery-devices-market

Calendar

September 2019
M T W T F S S
« Aug    
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Recent Posts

Drone Transponders Market Size, Share, Trends, Segments and Geographic Overview by Leading Players to 2023

Read Full Article

Categories